PetMed Express (PETS) Q1 FY27 earnings call

Earnings call· Jun 2026 (Q1 FY27)· Consumer Discretionary· Aug 13, 2026

Source: earnings call transcript

Executive summary

PetMed Express Q1 FY27 — Net Loss Narrows, Customer Acquisition Improves

PetMed Express continued its operational and financial transformation in Q1 FY27, narrowing its net loss significantly due to cost management and the absence of a prior-year impairment charge. The company focused on diversifying customer acquisition, improving efficiency through technology upgrades, and strengthening its balance sheet via a planned sale-leaseback, while navigating a competitive pet health landscape and evaluating an unsolicited acquisition proposal.

Highlights

Net loss narrowed significantly to $6.1 million, down from $34.2 million in the prior year.
Cost of acquiring a new customer (CAC) reduced by 15% to $60 in Q1 FY27.
Recurring net sales grew to 61.5% of total gross sales, up from 57.6% year-over-year.
Acquired approximately 70,000 new customers in the quarter.

Concerns

Net sales declined 19.9% year-over-year to $41 million due to continued softness in prescription medication sales.
Adjusted EBITDA loss widened to $3.4 million from $2.7 million in the prior year.
Gross profit as a percentage of sales slightly declined to 27.6% from 28.1% year-over-year.

Product announcements

Product	Type	Timeline	Details
Rural King co-branded online pharmacy offering	launch	July 2026

Deals & partnerships

SilverCape Investments Unsolicited, non-binding, and conditional proposal to acquire all outstanding shares of the company's stock. $3 per share in cash

The Board has not yet reached any determination regarding SilverCape's proposal, and there is no assurance that any transaction will result. The company does not intend to comment further unless and until it determines that additional disclosure is appropriate or required.

Rural King Co-branded online pharmacy offering, representing PetMeds' first large-scale white-label pharmacy program.

Launched in July, this partnership provides Rural King's customers across more than 150 stores in 17 states with access to pet medications, prescription food, preventatives, and AutoShip services through a platform powered by PetMeds.

Undisclosed buyer Sale-leaseback of headquarters and distribution center buildings in Delray Beach, Florida. $37 million 10-year lease with subsequent renewal options

Under the agreement, PetMeds will lease back the portion of the property housing its offices and Florida distribution center. The transaction is subject to a due diligence period, negotiation of the definitive lease agreement, and other customary closing conditions.

Risks & headwinds

Competitive pet health landscape Ongoing

Intensely competitive

Mitigation:Focus on enhancing shareholder value, optimizing capital allocation, streamlining cost structure, developing new revenue streams, improving customer retention, modernizing technology, and enhancing customer service.

Softness in prescription medication sales Q1 FY27

Reflected in 19.9% year-over-year net sales decline to $41 million.

Mitigation:Diversifying customer acquisition funnel, strategic initiatives like white-label pharmacy offerings.

Increasing advertising costs Ongoing

Traditional advertising and media channels continue to become more expensive.

Mitigation:Diversifying customer acquisition funnel, optimizing advertising and media spend, selective elimination of unproductive, high-cost programs, resulting in a 15% reduction in CAC.

Lower manufacturer rebates Q1 FY27

Lower manufacturer rebates as a percentage of sales, contributing to a slight decline in gross profit margin from 28.1% to 27.6%.

Mitigation:Partially offset by lower freight costs per order.

What to watch in Q2 FY27

Sale-Leaseback Transaction Closure

Within 120 days from July 23, 2026

Current Definitive agreement signed for $37M

Target Transaction closure

Why it matters

Unlocks real estate value and provides significant financial flexibility for strategic investments.

We expect this transaction to close within approximately 120 days from the date of the definitive agreement, subject to a due diligence period, negotiation of the definitive lease agreement, and other customary closing conditions.

Find out whether PETS delivers this. Inve re-checks your case every morning.

2 min read 5 chapters

Detailed narrative

Operational and Technology Transformation

PetMed Express completed a comprehensive process to upgrade its enterprise resource planning (ERP) system, successfully rolling out SAP enterprise-wide in May. This represents the completion of one of the largest elements of its technology transformation initiative. Additionally, a new call center platform was launched in June to handle customer inquiries and sales more efficiently, and a new fraud prevention system, launched in Q4, continues to protect the business.

These initiatives aim to create a stronger foundation for a more scalable and efficient organization.

Customer Acquisition and Retention Initiatives

The company is diversifying its customer acquisition funnel beyond traditional advertising, which is becoming more expensive. In Q1, PetMeds acquired approximately 70,000 new customers, a metric that has been trending upward. The cost of acquiring a new customer was reduced by 15% to $60, down from $71 in the same period last year, driven by marketing optimization.

Recurring net sales, including AutoShip and membership-related revenue, grew to 61.5% of total gross sales, up from 57.6% a year ago, underscoring the strength of its subscription-driven customer base.

Strategic Partnerships and New Revenue Streams

In July, PetMeds officially launched a new co-branded online pharmacy offering with Rural King, providing customers across more than 150 stores in 17 states access to pet medications and services through a platform powered by PetMeds. This partnership is the company's first large-scale white-label pharmacy program and is seen as an important proof point for efficiently growing customer acquisition reach and developing new revenue streams.

The company looks forward to announcing extensions of this white-label offering to additional partners.

Capital Allocation and Balance Sheet Optimization

On July 23, PetMeds announced a definitive agreement for a sale-leaseback of its headquarters and distribution center buildings in Delray Beach, Florida, for an aggregate purchase price of $37 million. The company will lease back a portion of the property under a 10-year lease with renewal options.

This transaction, expected to close within approximately 120 days, is intended to sharpen focus on the core pharmacy business, strengthen the balance sheet, and unlock real estate value, providing additional financial flexibility.

Unsolicited Acquisition Proposal and CEO Search

PetMeds acknowledged receipt of an unsolicited, non-binding, and conditional proposal from SilverCape Investments to acquire all outstanding shares for $3 per share in cash. The Board has not yet reached a determination regarding this proposal. Separately, the Board is continuing its search for a permanent CEO with the assistance of a global executive search firm, prioritizing a candidate committed to driving long-term shareholder value and sustainable profitability.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.